GLRB allelic variation associated with agoraphobic cognitions, increased startle response and fear network activation: a potential neurogenetic pathway to panic disorder

Molecular Psychiatry

Volumn 22, Issue 10, 2017, Pages 1431-1439

  Deckert, J ^a   Weber, H ^a,b   Villmann, C ^a   Lonsdorf, T B ^c   Richter, J ^d   Andreatta, M ^e   Arias Vasquez, A ^f   Hommers, L ^a   Kent, L ^g   Schartner, C ^a   Cichon, S ^h,i,j,k   Wolf, C ^a   Schaefer, N ^a   von Collenberg, C R ^a   Wachter, B ^a   Blum, R ^a   Schumann D ^c   Scharfenort, R ^c   Schumacher, J ^h,i   Forstner, A J ^h,i   Baumann, C ^a   Schiele, M A ^a   Notzon, S ^l   Zwanzger, P ^l,m   Janzing, J G E ⁿ   Galesloot, T ⁿ   Kiemeney, L A ⁿ   Gajewska, A ^a   Glotzbach Schoon, E ^e   Muhlberger A ^o   Alpers, G ^p   Fydrich, T ^q   Fehm, L ^q   Gerlach, A L ^r   Kircher, T ^s   Lang, T ^t,u,v   Strohle A ^w   Arolt, V ^l   Wittchen, H U ^t   Kalisch, R ^x   Buchel C ^c   Hamm, A ^d   Nothen M M ^h,i   Romanos, M ^a   Domschke, K ^a   Pauli, P ^e   Reif, A ^b   more..

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITY OF GREIFSWALD   (Germany)

^e UNIVERSITY OF WÜRZBURG   (Germany)

^f RADBOUD UNIVERSITY   (Netherlands)

^g UNIVERSITY OF ST ANDREWS   (United Kingdom)

^h UNIVERSITY OF BONN   (Germany)

ⁱ UNIVERSITY HOSPITAL BONN   (Germany)

^j UNIVERSITY HOSPITAL BASEL   (Switzerland)

^k FORSCHUNGSZENTRUM JÜLICH   (Germany)

^l UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^m District Hospital Gabersee   (Germany)

ⁿ RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^o UNIVERSITY OF REGENSBURG   (Germany)

^p UNIVERSITY OF MANNHEIM   (Germany)

^q HUMBOLDT UNIVERSITY   (Germany)

^r UNIVERSITY OF COLOGNE   (Germany)

^s UNIVERSITY HOSPITAL MARBURG   (Germany)

^t DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^u Christoph Dornier Foundation for Clinical Psychology   (Germany)

^v UNIVERSITY OF HAMBURG   (Germany)

^w CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^x UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLRB PROTEIN, HUMAN; GLYCINE RECEPTOR;

ADULT; AGORAPHOBIA; ALLELE; ANXIETY; ANXIETY DISORDER; BRAIN; CASE CONTROL STUDY; COGNITION; COMPLICATION; FEAR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GERMANY; HUMAN; MALE; METABOLISM; MUTATION; PANIC; PHYSIOLOGY; PSYCHOLOGY; STARTLE REFLEX;

ADULT; AGORAPHOBIA; ALLELES; ANXIETY; ANXIETY DISORDERS; BRAIN; CASE-CONTROL STUDIES; COGNITION; FEAR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GERMANY; HUMANS; MALE; MUTATION; PANIC DISORDER; RECEPTORS, GLYCINE; REFLEX, STARTLE;

EID: 85011649906     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2017.2     Document Type: Article

References (71)

1. Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jonsson B et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011; 21: 655–679. DOI: 10.1016/j.euroneuro.2011.07.018
2. Hofmann SG, Alpers GW, Pauli P. Phenomenology of Panic and Phobic Disorders. Oxford University Press: New York, NY, USA, 2008. DOI: 10.1093/oxfordhb/9780195307030.013.0003
3. Walz N, Mühlberger A, Pauli P. A human open field test reveals thigmotaxis related to agoraphobic fear. Biol Psychiatry 2016; 80: 390–397. DOI: 10.1016/j.biopsych.2015.12.016
4. Pauli P, Amrhein C, Muhlberger A, Dengler W, Wiedemann G. Electrocortical evidence for an early abnormal processing of panic-related words in panic disorder patients. Int J Psychophysiol 2005; 57: 33–41. DOI: 10.1016/j.ijpsycho.2005.01.009
5. Chambless DL, Caputo GC, Bright P, Gallagher R. Assessment of fear of fear in agoraphobics: the body sensations questionnaire and the agoraphobic cognitions questionnaire. J Consult Clin Psychol 1984; 52: 1090–1097. DOI: 10.1037/0022-006X.52.6.1090
6. Fyer AJ, Mannuzza S, Chapman TF, Martin LY, Klein DF. Specificity in familial aggregation of phobic disorders. Arch Gen Psychiatry 1995; 52: 564–573. DOI: 10.1001/archpsyc.1995.03950190046007
7. Noyes R Jr., Crowe RR, Harris EL, Hamra BJ, McChesney CM, Chaudhry DR. Relationship between panic disorder and agoraphobia. A family study. Arch Gen Psychiatry 1986; 43: 227–232. DOI: 10.1001/archpsyc.1986.01800030037004
8. Mosing MA, Gordon SD, Medland SE, Statham DJ, Nelson EC, Heath AC et al. Genetic and environmental influences on the co-morbidity between depression, panic disorder, agoraphobia, and social phobia: a twin study. Depress Anxiety 2009; 26: 1004–1011. DOI: 10.1002/da.20611
9. Gottschalk MG, Domschke K. Novel developments in genetic and epigenetic mechanisms of anxiety. Curr Opin Psychiatry 2016; 29: 32–38. DOI: 10.1097/YCO.0000000000000219
10. Hamilton SP. Linkage and association studies of anxiety disorders. Depress Anxiety 2009; 26: 976–983. DOI: 10.1002/da.20615
11. Howe AS, Buttenschon HN, Bani-Fatemi A, Maron E, Otowa T, Erhardt A et al. Candidate genes in panic disorder: meta-analyses of 23 common variants in major anxiogenic pathways. Mol Psychiatry 2015; 21: 665–679. DOI: 10.1038/mp.2015.138
12. Maron E, Hettema JM, Shlik J. Advances in molecular genetics of panic disorder. Mol Psychiatry 2010; 15: 681–701. DOI: 10.1038/mp.2009.145
13. Domschke K, Freitag CM, Kuhlenbaumer G, Schirmacher A, Sand P, Nyhuis P et al. Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women. Int J Neuropsychopharmacol 2004; 7: 183–188. DOI: 10.1017/S146114570400416X
14. Hamilton SP, Slager SL, Heiman GA, Deng Z, Haghighi F, Klein DF et al. Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22. Biol Psychiatry 2002; 51: 591–601. DOI: 10.1016/S0006-3223(01)01322-1
15. Rothe C, Koszycki D, Bradwejn J, King N, Deluca V, Tharmalingam S et al. Association of the Val158Met catechol O-methyltransferase genetic polymorphism with panic disorder. Neuropsychopharmacology 2006; 31: 2237–2242. DOI: 10.1038/sj.npp.1301048
16. Domschke K, Reif A, Weber H, Richter J, Hohoff C, Ohrmann P et al. Neuropeptide S receptor gene — converging evidence for a role in panic disorder. Mol Psychiatry 2010; 16: 938–948. DOI: 10.1038/mp.2010.81
17. Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O, Di Bella D et al. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 1999; 8: 621–624. DOI: 10.1093/hmg/8.4.621
18. Domschke K, Tidow N, Kuithan H, Schwarte K, Klauke B, Ambree O et al. Monoamine oxidase A gene DNA hypomethylation - a risk factor for panic disorder? Int J Neuropsychopharmacol 2012; 15: 1217–1228. DOI: 10.1017/S146114571200020X
19. Reif A, Richter J, Straube B, Hofler M, Lueken U, Gloster AT et al. MAOA and mechanisms of panic disorder revisited: from bench to molecular psychotherapy. Mol Psychiatry 2014; 19: 122–128. DOI: 10.1038/mp.2012.172
20. Domschke K, Deckert J, O'Donovan M C, Glatt SJ. Meta-analysis of COMT val158met in panic disorder: ethnic heterogeneity and gender specificity. Am J Med Genet B Neuropsychiatric Genet 2007; 144B: 667–673. DOI: 10.1002/ajmg.b.30494
21. Reif A, Weber H, Domschke K, Klauke B, Baumann C, Jacob CP et al. Meta-analysis argues for a female-specific role of MAOA-uVNTR in panic disorder in four European populations. Am Med Genet B Neuropsychiatric Genet 2012; 159B: 786–793. DOI: 10.1002/ajmg.b.32085
22. Erhardt A, Czibere L, Roeske D, Lucae S, Unschuld PG, Ripke S et al. TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. Mol Psychiatry 2011; 16: 647–663. DOI: 10.1038/mp.2010.41
23. Otowa T, Kawamura Y, Nishida N, Sugaya N, Koike A, Yoshida E et al. Meta-analysis of genome-wide association studies for panic disorder in the Japanese population. Transl Psychiatry 2012; 2: e186. DOI: 10.1038/tp.2012.89
24. Otowa T, Yoshida E, Sugaya N, Yasuda S, Nishimura Y, Inoue K et al. Genome-wide association study of panic disorder in the Japanese population. J Hum Genet 2009; 54: 122–126. DOI: 10.1038/jhg.2008.17
25. Erhardt A, Akula N, Schumacher J, Czamara D, Karbalai N, Muller-Myhsok B et al. Replication and meta-analysis of TMEM132D gene variants in panic disorder. Transl Psychiatry 2012; 2: e156. DOI: 10.1038/tp.2012.85
26. Schizophrenia Working Group of the Psychiatric Genomics C. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511: 421–427. DOI: 10.1038/nature13595
27. Fullerton JM, Willis-Owen SA, Yalcin B, Shifman S, Copley RR, Miller SR et al. Human-mouse quantitative trait locus concordance and the dissection of a human neuroticism locus. Biol Psychiatry 2008; 63: 874–883. DOI: 10.1016/j.biopsych.2007.10.019
28. Shifman S, Bhomra A, Smiley S, Wray NR, James MR, Martin NG et al. A whole genome association study of neuroticism using DNA pooling. Mol Psychiatry 2008; 13: 302–312. DOI: 10.1038/sj.mp.4002048
29. Walter S, Glymour MM, Koenen K, Liang L, Tchetgen Tchetgen EJ, Cornelis M et al. Performance of polygenic scores for predicting phobic anxiety. PloS One 2013; 8: e80326. DOI: 10.1371/journal.pone.0080326
30. Otowa T, Hek K, Lee M, Byrne EM, Mirza SS, Nivard MG et al. Meta-analysis of genome-wide association studies of anxiety disorders. Mol Psychiatry 2016; 21: 1485. DOI: 10.1038/mp.2016.11
31. Otowa T, Maher BS, Aggen SH, McClay JL, van den Oord EJ, Hettema JM. Genome-wide and gene-based association studies of anxiety disorders in European and African American samples. PloS One 2014; 9: e112559. DOI: 10.1371/journal.pone.0112559
32. Ehlers A, Margraf J Fragebogen zu körperbezogenen Ängsten, Kognitionen und Vermeidung (AKV). Beltz Test 2001; Göttingen.
33. Domschke K, Gajewska A, Winter B, Herrmann MJ, Warrings B, Muhlberger A et al. ADORA2A Gene variation, caffeine, and emotional processing: a multi-level interaction on startle reflex. Neuropsychopharmacology 2012; 37: 759–769. DOI: 10.1038/npp.2011.253
34. Schiele MA, Ziegler C, Holitschke K, Schartner C, Schmidt B, Weber H et al. Influence of 5-HTT variation, childhood trauma and self-efficacy on anxiety traits: a gene-environment-coping interaction study. J Neural Transmission 2016; 123: 895–904. DOI: 10.1007/s00702-016-1564-z
35. Hoogendoorn EH, Hermus AR, de Vegt F, Ross HA, Verbeek AL, Kiemeney LA et al. Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin Chemistry 2006; 52: 104–111. DOI: 10.1373/clinchem.2005.055194
36. Derogatis LR, Cleary PA. Factorial invariance across gender for the primary symptom dimensions of the SCL-90. Br J Social Clin Psychol 1977; 16: 347–356. DOI: 10.1111/j.2044-8260.1977.tb00241.x
37. Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale—preliminary report. Psychopharmacol Bull 1973; 9: 13–28.
38. Arrindell WA, Ettema JHM. SCL-90, Handleiding bij een Multidimensionele Psychopathologie Indicator. Swets & Zeitlinger: Lisse, The Netherlands, 1986.
39. Gloster AT, Wittchen HU, Einsle F, Hofler M, Lang T, Helbig-Lang S et al. Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia. Eur Arch Psychiatry Clin Neurosci 2009; 259 (Suppl 2): S155–S166. DOI: 10.1007/s00406-009-0065-6
40. Weber H, Richter J, Straube B, Lueken U, Domschke K, Schartner C et al. Allelic variation in CRHR1 predisposes to panic disorder: evidence for biased fear processing. Mol Psychiatry 2015; 21: 813–822. DOI: 10.1038/mp.2015.125
41. Rietschel M, Mattheisen M, Degenhardt F, Genetic R, Outcome in P, Muhleisen TW et al. Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe. Mol Psychiatry 2012; 17: 906–917. DOI: 10.1038/mp.2011.80
42. Fuchsberger C, Abecasis GR, Hinds DA. minimac2: faster genotype imputation. Bioinformatics 2015; 31: 782–784. DOI: 10.1093/bioinformatics/btu704
43. Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 2010; 34: 816–834. DOI: 10.1002/gepi.20533
44. Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM et al. A global reference for human genetic variation. Nature 2015; 526: 68–74. DOI: 10.1038/nature15393
45. Weber H, Klamer D, Freudenberg F, Kittel-Schneider S, Rivero O, Scholz CJ et al. The genetic contribution of the NO system at the glutamatergic post-synapse to schizophrenia: further evidence and meta-analysis. Eur Neuropsychopharmacol 2013; 24: 65–85. DOI: 10.1016/j.euroneuro.2013.09.005
46. Glotzbach-Schoon E, Andreatta M, Reif A, Ewald H, Troger C, Baumann C et al. Contextual fear conditioning in virtual reality is affected by 5HTTLPR and NPSR1 polymorphisms: effects on fear-potentiated startle. Front Behav Neurosci 2013; 7: 31. DOI: 10.3389/fnbeh.2013.00031
47. Richter J, Hamm AO, Pane-Farre CA, Gerlach AL, Gloster AT, Wittchen HU et al. Dynamics of defensive reactivity in patients with panic disorder and agoraphobia: implications for the etiology of panic disorder. Biol Psychiatry 2012; 72: 512–520. DOI: 10.1016/j.biopsych.2012.03.035
48. Scharfenort R, Lonsdorf TB. Neural correlates of and processes underlying generalized and differential return of fear. Soc Cogn Affect Neurosci 2015; 11: 612–620. DOI: 10.1093/scan/nsv142
49. Boucsein W, Fowles DC, Grimnes S, Ben-Shakhar G, Roth WT, Dawson ME et al. Publication recommendations for electrodermal measurements. Psychophysiology 2012; 49: 1017–1034. DOI: 10.1111/j.1469-8986.2012.01384.x
50. Becker K, Braune M, Benderska N, Buratti E, Baralle F, Villmann C et al. A retroelement modifies pre-mRNA splicing: the murine Glrb(spa) allele is a splicing signal polymorphism amplified by long interspersed nuclear element insertion. J Biol Chem 2012; 287: 31185–31194. DOI: 10.1074/jbc.M112.375691
51. Kingsmore SF, Giros B, Suh D, Bieniarz M, Caron MG, Seldin MF. Glycine receptor beta-subunit gene mutation in spastic mouse associated with LINE-1 element insertion. Nat Genet 1994; 7: 136–141. DOI: 10.1038/ng0694-136
52. Crawley JN, Paylor R. A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice. Hormones Behav 1997; 31: 197–211. DOI: 10.1006/hbeh.1997.1382
53. Cuthbert BN, Insel TR. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med 2013; 11: 126. DOI: 10.1186/1741-7015-11-126
54. Hamm AO, Richter J, Pane-Farre C, Westphal D, Wittchen HU, Vossbeck-Elsebusch AN et al. Panic disorder with agoraphobia from a behavioral neuroscience perspective: applying the research principles formulated by the Research Domain Criteria (RDoC) initiative. Psychophysiology 2016; 53: 312–322. DOI: 10.1111/psyp.12553
55. McNally RJ. Anxiety sensitivity and panic disorder. Biol Psychiatry 2002; 52: 938–946. DOI: 10.1016/S0006-3223(02)01475-0
56. Godemann F, Schabowska A, Naetebusch B, Heinz A, Strohle A. The impact of cognitions on the development of panic and somatoform disorders: a prospective study in patients with vestibular neuritis. Psychol Med 2006; 36: 99–108. DOI: 10.1017/S0033291705005921
57. Kaabi B, Gelernter J, Woods SW, Goddard A, Page GP, Elston RC. Genome scan for loci predisposing to anxiety disorders using a novel multivariate approach: strong evidence for a chromosome 4 risk locus. Am J Hum Genet 2006; 78: 543–553. DOI: 10.1086/501072
58. Lynch JW. Molecular structure and function of the glycine receptor chloride channel. Physiol Rev 2004; 84: 1051–1095. DOI: 10.1152/physrev.00042.2003
59. Schaefer N, Langlhofer G, Kluck CJ, Villmann C. Glycine receptor mouse mutants: model systems for human hyperekplexia. Br J Pharmacol 2013; 170: 933–952. DOI: 10.1111/bph.12335
60. Chung SK, Bode A, Cushion TD, Thomas RH, Hunt C, Wood SE et al. GLRB is the third major gene of effect in hyperekplexia. Hum Mol Genet 2013; 22: 927–940. DOI: 10.1093/hmg/dds498
61. James VM, Bode A, Chung SK, Gill JL, Nielsen M, Cowan FM et al. Novel missense mutations in the glycine receptor beta subunit gene (GLRB) in startle disease. Neurobiol Dis 2013; 52: 137–149. DOI: 10.1016/j.nbd.2012.12.001
62. Becker CM. Disorders of the inhibitory glycine receptor: the spastic mouse. FASEB J 1990; 4: 2767–2774. DOI: 10.1096/fasebj.4.10.2165011
63. Al-Owain M, Colak D, Al-Bakheet A, Al-Hashmi N, Shuaib T, Al-Hemidan A et al. Novel mutation in GLRB in a large family with hereditary hyperekplexia. Clin Genet 2012; 81: 479–484. DOI: 10.1111/j.1399-0004.2011.01661.x
64. Tijssen MAJ, Rees MI. Hyperekplexia. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH et al (eds). GeneReviews(R). University of Washington: Seattle, WA, USA, 2012.
65. Anokhin AP, Golosheykin S, Heath AC. Genetic and environmental influences on emotion-modulated startle reflex: a twin study. Psychophysiology 2007; 44: 106–112. DOI: 10.1111/j.1469-8986.2006.00486.x
66. Vaidyanathan U, Malone SM, Miller MB, McGue M, Iacono WG. Heritability and molecular genetic basis of acoustic startle eye blink and affectively modulated startle response: a genome-wide association study. Psychophysiology 2014; 51: 1285–1299. DOI: 10.1111/psyp.12348
67. Davis M, Walker DL, Miles L, Grillon C. Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology 2010; 35: 105–135. DOI: 10.1038/npp.2009.109
68. Li P, Slaughter M. Glycine receptor subunit composition alters the action of GABA antagonists. Vis Neurosci 2007; 24: 513–521. DOI: 10.1017/S0952523807070368
69. Aroeira RI, Ribeiro JA, Sebastiao AM, Valente CA. Age-related changes of glycine receptor at the rat hippocampus: from the embryo to the adult. J Neurochem 2011; 118: 339–353. DOI: 10.1111/j.1471-4159.2011.07197.x
70. Jonsson S, Morud J, Pickering C, Adermark L, Ericson M, Soderpalm B. Changes in glycine receptor subunit expression in forebrain regions of the Wistar rat over development. Brain Res 2012; 1446: 12–21. DOI: 10.1016/j.brainres.2012.01.050
71. Goldman D, Domschke K. Making sense of deep sequencing. Int J Neuropsychopharmacol 2014; 17: 1717–1725. DOI: 10.1017/S1461145714000789